Accent Microcell

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Q5D01013
  • NSEID: ACCENTMIC
  • BSEID:
INR
464.30
-1.75 (-0.38%)
BSENSE

Jun 24, 03:30 PM

BSE+NSE Vol: 11500

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 7.77% vs 24.45% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 6.17% vs 108.28% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -69.85% vs -54.77% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 9.60% vs 146.63% in Mar 2024

Compare Profit and Loss Results of Accent Microcell
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
264.00
623.00
-359.00
-57.62%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
264.00
623.00
-359.00
-57.62%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
8.00
-11.00
-137.50%
Raw Materials Consumed
165.00
282.00
-117.00
-41.49%
Power & Fuel Cost
20.00
11.00
9.00
81.82%
Employee Cost
15.00
112.00
-97.00
-86.61%
Operating Expenses
9.00
27.00
-18.00
-66.67%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
9.00
28.00
-19.00
-67.86%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
3.00
-2.00
-66.67%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
222.00
521.00
-299.00
-57.39%
Operating Profit (PBDIT) excl Other Income
41.00
101.00
-60.00
-59.41%
Other Income
6.00
22.00
-16.00
-72.73%
Operating Profit (PBDIT)
48.00
123.00
-75.00
-60.98%
Interest
0.00
1.00
-1.00
-100.00%
Profit before Depriciation and Tax
47.00
122.00
-75.00
-61.48%
Depreciation
4.00
12.00
-8.00
-66.67%
Profit Before Taxation & Exceptional Items
43.00
109.00
-66.00
-60.55%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
43.00
109.00
-66.00
-60.55%
Provision for Tax
10.00
26.00
-16.00
-61.54%
Profit After Tax
33.00
82.00
-49.00
-59.76%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
65.00
507.00
-442.00
-87.18%
Profit Available for appropriations
98.00
589.00
-491.00
-83.36%
Appropriations
98.00
589.00
-491.00
-83.36%
Equity Dividend (%)
10%
18%
-8.00
Earnings Per Share
15.71
41.11
-25.40
-61.79%
Profit And Loss - Net Sales
Net Sales 264.58 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 7.77% vs 24.45% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 41.91 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 6.17% vs 108.28% in Mar 2024

Profit And Loss - Interest
Interest 0.35 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -69.85% vs -54.77% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 33.06 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 9.60% vs 146.63% in Mar 2024